TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05920057

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: constructive emotional management interventions
Description: The Constructive emotional management interventions sessions were conducted in the activity rooms of the elderly clubs where the researchers met the participants. Participants completed a baseline evaluation of the outcome measures of the researched variables after being found to be eligible for the current study and indicating their willingness to participate willingly. After explaining the study's objectives to participants, the researchers themselves delivered the Constructive Emotional Management Interventions program, which had been vetted by experts in the field.
Study: NCT05334992

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy
Description: Individual therapy 12 to 16 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavior Activation
Description: Individual therapy 12 to 16 weeks
Study: NCT06474780

Intervention type: DEVICE
Intervention: Weight: 414g Size: 19.5cm x 14cm x 11cm Compatibility: Android and iOS VR Box 3.0 3D Virtual Reality Glasses Has the Feature of Fixation with Headband It has a lens mechanism tha
Description: Patients in the experimental group were fitted with virtual reality glasses for 3 cycles and were allowed to watch videos of city tours, walks in the forest, and nature walks for 15 minutes, depending on their choice.
Study: NCT04926337

Intervention type: DEVICE
Intervention: Tight Fitting Facemask
Description: Preoxygenation with tight facemask, 10 L/min, 100% oxygen.

Intervention type: DEVICE
Intervention: High Flow Nasal Oxygen (HFNO)
Description: Preoxygenation with high flow nasal oxygen, 40-70 L/min, 100% oxygen.
Study: NCT06066359

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine phosphate
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine phosphate
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine phosphate
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine phosphate
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NY-ESO-1 TCR/IL-15 NK
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NY-ESO-1 TCR/IL-15 NK
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NY-ESO-1 TCR/IL-15 NK
Description: Given by (IV) vein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NY-ESO-1 TCR/IL-15 NK
Description: Given by (IV) vein
Study: NCT05689801

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire recovery time after a dialysis session.
Description: A very short questionnaire just after the dialysis session
Study: NCT06531070

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nitrate
Description: A four-day supplementation period, separated by one week including a 3-day washout period between conditions will be applied before conducting strength and endurance assessments~Days 1 to 3 the randomly assigned supplement (N, NC, or PLA) will be ingested 2 hr before a standard low-volume training session including 3 sets of 8 to 10 reps of squat and deadlift using a very light load (e.g., own body mass) and flexibility exercises following by 5 min of running at self-paced intensity rated as light (12) with the rating of perceived exertion Borg Scale.~Day 4: the assigned supplement will be ingested 2.5 h before the assessments~Assessment of strength and endurance will be conducted

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nitrate
Description: A four-day supplementation period, separated by one week including a 3-day washout period between conditions will be applied before conducting strength and endurance assessments~Days 1 to 3 the randomly assigned supplement (N, NC, or PLA) will be ingested 2 hr before a standard low-volume training session including 3 sets of 8 to 10 reps of squat and deadlift using a very light load (e.g., own body mass) and flexibility exercises following by 5 min of running at self-paced intensity rated as light (12) with the rating of perceived exertion Borg Scale.~Day 4: the assigned supplement will be ingested 2.5 h before the assessments~Assessment of strength and endurance will be conducted

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Nitrate
Description: A four-day supplementation period, separated by one week including a 3-day washout period between conditions will be applied before conducting strength and endurance assessments~Days 1 to 3 the randomly assigned supplement (N, NC, or PLA) will be ingested 2 hr before a standard low-volume training session including 3 sets of 8 to 10 reps of squat and deadlift using a very light load (e.g., own body mass) and flexibility exercises following by 5 min of running at self-paced intensity rated as light (12) with the rating of perceived exertion Borg Scale.~Day 4: the assigned supplement will be ingested 2.5 h before the assessments~Assessment of strength and endurance will be conducted
Study: NCT05778201

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Baby Drink group
Description: 1 packge (20 ml)/ day for 1 month
Study: NCT05689801

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SF-12 questionnaire
Description: Questionnaire about quality of life of the patient
Study: NCT05431608

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MCARH109
Description: MCARH109 and MCARH125 will be administered 2-7 days following the completion of conditioning chemotherapy. Each dose cohort will consist of 3-6 patients. MCARH109 and MCARH125 will be administered sequentially with 5-30 minutes between the two products.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MCARH109
Description: MCARH109 and MCARH125 will be administered 2-7 days following the completion of conditioning chemotherapy. Each dose cohort will consist of 3-6 patients. MCARH109 and MCARH125 will be administered sequentially with 5-30 minutes between the two products.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MCARH109
Description: MCARH109 and MCARH125 will be administered 2-7 days following the completion of conditioning chemotherapy. Each dose cohort will consist of 3-6 patients. MCARH109 and MCARH125 will be administered sequentially with 5-30 minutes between the two products.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MCARH109
Description: MCARH109 and MCARH125 will be administered 2-7 days following the completion of conditioning chemotherapy. Each dose cohort will consist of 3-6 patients. MCARH109 and MCARH125 will be administered sequentially with 5-30 minutes between the two products.
Study: NCT04914520

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total
Study: NCT06074393

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Support Group
Description: Participants engage in a secure, confidential environment, sharing caregiving insights and knowledge. Expert-led sessions, lasting 90 minutes, occur biweekly for 16 weeks, held via Zoom and at the University of Calgary's Cumming School of Medicine. These sessions take place twice annually, emphasizing the structured nature of the support group. Weekly themes include self-care, adaptation, coping skills, emotions, anticipatory grief, forgiveness, mindfulness, boundaries, and closure. Care partners actively participate by sharing experiences and asking questions in each session.
Study: NCT04750889

Intervention type: DEVICE
Intervention: RFID tags
Description: Installation of the RFID tag device wire localization)

Intervention type: DEVICE
Intervention: Wire localization
Description: Installation of the wire localization device
Study: NCT04712214

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intra-operative multispectral / hyperspectral analysis
Description: During surgery, the operating surgeon will be using standard NHS neurosurgical equipment such as an endoscope and/or a microscope. This equipment is operated in exactly the same way as with any other procedure, but either the microscope or the endoscope in use will be connected to the system of camera and filters for multispectral/hyperspectral analysis. During each surgical intervention, tissue-specific spectral data will be collected at specific stages - mostly once the brain surface is exposed and at the end of the resection on the surgical cavity. The operation will be visually recorded in order to sync visual data with the spectral data obtained at the same moment in time. The video recording will not be patient identifiable and will be viewed only by members of the research team working on this project (see below). The use of video recording equipment will be included in the patient information sheet given to all patients prior to gaining consent
Study: NCT04914520

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total
Study: NCT06090253

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gerotechnology enhanced multi-component exercise
Description: Intervention courses will be divided into 3 categories: Musculoskeletal training course, Neuromuscular and fall prevention training course, and cardiometabolic training course. The courses will be enabled by wearable technology, digital platform and visual display. Each of the courses will be 8 weeks in length (1 session per week), and 60 minutes per session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gerotechnology enhanced multi-component exercise
Description: Intervention courses will be divided into 3 categories: Musculoskeletal training course, Neuromuscular and fall prevention training course, and cardiometabolic training course. The courses will be enabled by wearable technology, digital platform and visual display. Each of the courses will be 8 weeks in length (1 session per week), and 60 minutes per session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based exercise
Description: The proposed elderly home gym training services will be conducted by professional fitness instructors and tailor-made for the participants. 4 personal training sessions will be assigned (once per week, 45 to 60 minutes per session).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Walking exercise
Description: Two interventions will be provided: A) Walk-focused intervention, B) Disease-related walk intervention for participants with chronic diseases.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Walking exercise
Description: Two interventions will be provided: A) Walk-focused intervention, B) Disease-related walk intervention for participants with chronic diseases.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Slow sports and exercise
Description: Participants will receive 10 training sessions (once or twice per week, 2 hours per session) conducted by professional fitness instructors. The training programs can be selected according to the participants' preference, including water exercises, stretching/fitness/gymnastics, slow walking/jogging, sports massage, Tai Chi, Yoga, etc.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Slow sports and exercise
Description: Participants will receive 10 training sessions (once or twice per week, 2 hours per session) conducted by professional fitness instructors. The training programs can be selected according to the participants' preference, including water exercises, stretching/fitness/gymnastics, slow walking/jogging, sports massage, Tai Chi, Yoga, etc.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Football
Description: The Football Training Programme will be arranged (10 training sessions+1 game day per stage, 4 stages per season). held on artificial turf football pitch or indoor sport facilities in 5 regions
Study: NCT06438549

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HCP-CHW Integration into Prenatal Care for Smoking Cessation
Description: CHWs will be integrated into primary care, and subjects will receive CHW home visits (up to 8) that will provide brief behavioral smoking cessation interventions before, during, and after a quit date. This brief behavioral intervention will include watching a video and reviewing self-help materials.

Intervention type: OTHER
Group type: OTHER
Intervention: Control Arm
Description: Standard of Care which provides referrals to community-based smoking cessation resources.
Study: NCT05480280

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib
Description: Dalpiciclib is orally administered at 125mg qd for 21 days and discontinue for 7 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin injection
Description: 85mg/m², ivdrip, D1
Study: NCT05576090

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Description: The mindful awareness practices (MAPS) for Sleep intervention is based on an institutional program developed by the Mindful Awareness Research Center (MARC) at UCLA. This intervention includes educational and behavioral content related to sleep, including the importance of regularity of sleep schedules, minimizing noise and light, and reducing caffeine use later in the day. Each session provides structured training and exercises in mindfulness, including formal meditation practices and strategies for the daily informal use of mindfulness, as well as opportunity for questions and group discussion. Home practice is a key component of MAPs and is particularly important for addressing sleep disturbance. Participants will be instructed to practice mindfulness techniques on a daily basis, beginning with five minutes and increasing to 20 minutes, with practice prior to bedtime, and to practice at night if they awake and cannot return to sleep.
Study: NCT05480280

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium folinate
Description: 400mg/m², ivdrip, D1; or calcium levofolinate, 200 mg/m², ivdrip, D1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Description: 400mg/m², iv, D1; and 2400mg/m², civ, 46-48h
Study: NCT05689801

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L Questionnaire
Description: Questionnaire about quality of life of the patient

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pittman, John et McIntyre questionnaire
Description: Questionnaire about quality of life of the patient under dialysis

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional hemodialysis
Description: patient on polyethersulfone membrane dialysis (Revaclear®, Baxter) with HemoControl™ for 12 weeks

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Optimized hemodialysis
Description: patient on Medium Cut-Off membrane dialysis (Theranova®, Baxter) with HemoControl™ for 12 weeks.
Study: NCT05346458

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intra coronary rapid-exchange iKOs microcatheter intervention
Description: Patients planned for an invasive coronary physiology (pressure-wire) study and who meet the inclusion criteria and none of the exclusion criteria can be enrolled. Participants will undergo preparation for their clinical procedure (angiogram with pressure wire study) in the normal manner. Arterial cannulation will be performed via the radial or femoral artery) under local anaesthesia. The sheath will be inserted and a pre-procedure blood sample taken for Troponin T level. A coronary angiogram will be performed as per standard clinical practice prior to cannulating the coronary artery to be studied. The pressure studies will be performed sequentially, first with a pressure wire before using the iKOs™ microcatheter. Following withdrawal of the iKOs™ microcatheter. A pressure wire assessment is repeated after the microcatheter is withdrawn. The case will then proceed as clinically indicated. Post-procedure the participant will be managed according to standard clinical practice.
Study: NCT05723406

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex 100 MG/ML [Bridion]
Description: 8 mg/ml

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sodium 0.9% 5 ml
Study: NCT06004518

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sexual counselling with PLISSIT model
Description: sexual counselling with PLISSIT model
Study: NCT06429813

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-Based Exercise Intervention - Walking
Description: 30 minutes of walking or light jogging a day at a moderate intensity for 30 minutes a day, 5 days a week for 12 weeks

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-Based Exercise Intervention - HIIT Cycling
Description: Four, 4 minute high intensity intervals of exercise, separated by 3 minutes of lower intensity exercise + a 10 minute warm up and 5 minute cool down for 40 minutes a day, 3 days a week for 12 weeks
Study: NCT05936775

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nano-hydroxy apatite coated titanium implants
Description: titanium implants with surface treatment of nano-hydroxy apatite

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sandblasted large acid itched coated titanium implant
Description: titanium implants with SLA surface treatment
Study: NCT04746001

Intervention type: DIAGNOSTIC_TEST
Intervention: Genomic sequencing
Description: Sequencing data

Intervention type: DIAGNOSTIC_TEST
Intervention: Genomic sequencing
Description: Sequencing data

Intervention type: DIAGNOSTIC_TEST
Intervention: Histological examination
Description: Images for deep learning

Intervention type: DIAGNOSTIC_TEST
Intervention: Histological examination
Description: Images for deep learning
Study: NCT04567680

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD
Description: This treatment is designed to help Veterans with PTSD increase social support in family, partner, and peer relationships by reducing experiential avoidance. ACT-SS is specifically designed to address deficits in the entire social support network for Veterans with PTSD.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Present-Centered Therapy
Description: PCT is designed to provide the emotional support for individuals with PTSD that will assist with recovery. The focus of PCT is on the here and now, including current life difficulties that are directly or indirectly related to the experience of trauma. PCT aims to help the patient consider ways to react to these difficulties.
Study: NCT05934409

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bariatric surgery
Description: Laparoscopic Sleeve Gastrectomy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Description: Laparoscopic Sleeve Gastrectomy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotinic Acid
Description: Only during A1. 150mg every half hour for 6 hours. A total dose of 1800mg will be ingested.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotinic Acid
Description: Only during A1. 150mg every half hour for 6 hours. A total dose of 1800mg will be ingested.
Study: NCT04768881

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Dose and formulation: 80 mg (4 tablets of 20 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Dose and formulation: 80 mg (4 tablets of 20 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Dose and formulation: 400 mg (25 milligrams per milliliter \[mg/mL\]) Solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Dose and formulation: 400 mg (25 milligrams per milliliter \[mg/mL\]) Solution
Study: NCT06509048

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: STN-DBS Theta Gamma Stimulation
Description: Standard STN-DBS stimulation with addiction of bilateral theta frequency stimulation of ventral contacts
Study: NCT05685355

Intervention type: DIAGNOSTIC_TEST
Intervention: Standardized intraoral photography
Description: Mouth photos will be taken with a plastic retractor to retract the subject's cheek and lips. This is a standard clinical procedure that is non-invasive and does not cause any harm or adverse effect on subjects.
Study: NCT05576090

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep Education
Description: The Sleep Education intervention provides education and behavioral content based on the National Institutes of Health and National Sleep Foundation tips for better sleep (e.g., changing poor sleep habits and establishing a bedtime routine). Each session provides didactic instruction, review of behavioral techniques, and opportunity for questions. Homework includes practicing sleep hygiene and weekly reading. Key components of the intervention include information about sleep biology, characteristics of healthy and unhealthy sleep, sleep problems, stress biology and stress reduction, self-monitoring of sleep behavior, relaxation methods for improving sleep, and weekly behavioral sleep hygiene strategies.